Medication use , particularly long-term metformin therapy, proton pump inhibitors, and H2-receptor antagonists, increases deficiency risk
In the meantime, UK patients with obesity or type 2 diabetes have access to several MHRA-licensed treatments supported by NICE guidance, including: Semaglutide (Wegovy for weight management
Monitoring how different protein sources affect your individual tolerancessome patients experience reduced nausea with softer or more processed proteins early in treatmenthelps refine your personal strategy
How Semaglutide Units Relate to Milligram Dosing The term 'units' in semaglutide therapy refers to the volume of medication delivered per injection, not a separate measurement standard like in insulin dosing
Chen H, Yang P, Xue P, Li S, Dan X, Li Y, et al